Methionine oxidation inhibits assembly and promotes disassembly of apolipoprotein C-II amyloid fibrils

Biochemistry

Volumn 47, Issue 38, 2008, Pages 10208-10217

  Binger, Katrina J ^a,b   Griffin, Michael D W ^a   Howlett, Geoffrey J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL OXYGEN DEMAND; DISSOCIATION; GLYCOPROTEINS; HYDROGEN; HYDROGEN PEROXIDE; NONMETALS; SELF ASSEMBLED MONOLAYERS; SYSTEM STABILITY;

AMYLOID DISEASES; AMYLOID FIBRIL FORMATION; AMYLOID FIBRILS; APOLIPOPROTEIN; APOLIPOPROTEIN C-II; CORE REGIONS; FIBRIL ASSEMBLY; FIBRIL FORMATION; IN-VITRO; IN-VIVO; INDUCED DISSOCIATION; INHIBITORY EFFECTS; METHIONINE OXIDATION; METHIONINE RESIDUES; SIDE CHAINS;

OXIDATION;

AMYLOID; APOLIPOPROTEIN C2; GLYCINE; HYDROGEN PEROXIDE; METHIONINE; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN DEFECT; PROTEIN STABILITY; STRUCTURAL PROTEOMICS;

AMYLOID; APOLIPOPROTEIN C-II; HUMANS; METHIONINE; OXIDATION-REDUCTION; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 52249123646     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi8009339     Document Type: Article

References (56)

1. Stadtman, E. R., and Levine, R. L. (2000) Protein oxidation. Ann. N.Y. Acad. Sci. 899, 191-208.
2. Vogt, W. (1995) Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radical Biol. Med. 18, 93-105.
3. Jung, S., Hansel, A., Kasperczyk, H., Hoshi, T., and Heinemann, S. H. (2002) Activity, tissue distribution and site-directed mutagenesis of a human peptide methionine sulfoxide reductase of type B: hCBS1. FEBS Lett. 527, 91-94.
4. Kuschel, L., Hansel, A., Schonherr, R., Weissbach, H., Brot, N., Hoshi, T., and Heinemann, S. H. (1999) Molecular cloning and functional expression of a human peptide methionine sulfoxide reductase (hMsrA). FEBS Lett. 456, 17-21.
5. Koc, A., and Gladyshev, V. N. (2007) Methionine sulfoxide reduction and the aging process. Ann. N. Y. Acad. Sci. 1100, 383-386.
6. Moskovitz, J., Bar-Noy, S., Williams, W. M., Requena, J., Berlett, B. S., and Stadtman, E. R. (2001) Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. U.S.A. 98, 12920-12925.
7. Levine, R. L., Mosoni, L., Berlett, B. S., and Stadtman, E. R. (1996) Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. U.S.A. 93, 15036-15040.
8. Taggart, C., Cervantes-Laurean, D., Kim, G., McElvaney, N. G., Wehr, N., Moss, J., and Levine, R. L. (2000) Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275, 27258-27265.
9. Butterfield, D. A., Drake, J., Pocernich, C., and Castegna, A. (2001) Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol. Med. 7, 548-554.
10. Chiti, F., and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366.
11. Westermark, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S., Frangione, B., Ikeda, S., Masters, C. L., Merlini, G., Saraiva, M. J., and Sipe, J. D. (2005) Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 12, 1-4.
12. Dobson, C. M. (2002) Getting out of shape. Nature 418, 729-730.
13. Sipe, J. D. (1992) Amyloidosis. Annu. Rev. Biochem. 61, 947-975.
14. Selkoe, D. J. (2003) Folding proteins in fatal ways. Nature 426, 900-904.
15. Hardy, J. A., and Higgins, G. A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
16. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
17. Walsh, D. M., Klyubin, L., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
18. Lynch, T., Cherny, R. A., and Bush, A. I. (2000) Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions. Exp. Gerontol. 35, 445-451.
19. Markesbery, W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol. Med. 23, 134-147.
20. Smith, D. G., Cappai, R., and Barnham, K. J. (2007) The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim. Biophys. Acta 1768, 1976-1990.
21. Barnham, K. J., Ciccotosto, G. D., Tickler, A. K., Ali, F. E., Smith, D. G., Williamson, N. A., Lam, Y. H., Carrington, D., Tew, D., Kocak, G., Volitakis, I., Separovic, F., Barrow, C. J., Wade, J. D., Masters, C. L., Cherny, R. A., Curtain, C. C., Bush, A. I., and Cappai, R. (2003) Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation. J. Biol. Chem. 278, 42959-42965.
22. Gabbita, S. P., Aksenov, M. Y., Lovell, M. A., and Markesbery, W. R. (1999) Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73, 1660-1666.
23. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., and Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511.
24. Bemporad, F., Calloni, G., Campioni, S., Plakoutsi, G., Taddei, N., and Chiti, F. (2006) Sequence and structural determinants of amyloid fibril formation. Acc. Chem. Res. 39, 620-627.
25. Monsellier, E., Ramazzotti, M., de Laureto, P. P., Tartaglia, G. G., Taddei, N., Fontana, A., Vendruscolo, M., and Chiti, F. (2007) The distribution of residues in a polypeptide sequence is a determinant of aggregation optimized by evolution. Biophys. J. 93, 4382-4391.
26. Pawar, A. P., Dubay, K. F., Zurdo, J., Chiti, F., Vendruscolo, M., and Dobson, C. M. (2005) Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J. Mol. Biol. 350, 379-392.
27. Hou, L., Kang, I., Marchant, R. E., and Zagorski, M. G. (2002) Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J. Biol. Chem. 277, 40173-40176.
28. Breydo, L., Bocharova, O. V., Makarava, N., Salnikov, V. V., Anderson, M., and Baskakov, I. V. (2005) Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation. Biochemistry 44, 15534-15543.
29. Maleknia, S. D., Reixach, N., and Buxbaum, J. N. (2006) Oxidation inhibits amyloid fibril formation of transthyretin. FEBS J. 273, 5400-5406.
30. Uversky, V. N., Yamin, G., Souillac, P. O., Goers, J., Glaser, C. B., and Fink, A. L. (2002) Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Lett. 517, 239-244.
31. Collinge, J., Beck, J., Campbell, T., Estibeiro, K., and Will, R. G. (1996) Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease. Lancet 348, 356.
32. Windl, O., Dempster, M., Estibeiro, J. P., Lathe, R., de Silva, R., Esmonde, T., Will, R., Springbett, A., Campbell, T. A., Sidle, K. C., Palmer, M. S., and Collinge, J. (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum. Genet. 98, 259-264.
33. Bergstrom, A. L., Chabry, J., Bastholm, L., and Heegaard, P. M. (2007) Oxidation reduces the fibrillation but not the neurotoxicity of the prion peptide PrP106-126. Biochim. Biophys. Acta 1774, 1118-1127.
34. Medeiros, L. A., Khan, T., El Khoury, J. B., Pham, C. L., Hatters, D. M., Howlett, G. J., Lopez, R., O'Brien, K. D., and Moore, K. J. (2004) Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J. Biol. Chem. 279, 10643-10648.
35. Stewart, C. R., Haw, A., III, Lopez, R., McDonald, T. O., Callaghan, J. M., McConville, M. J., Moore, K. J., Howlett, G. J., and O'Brien, K. D. (2007) Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications. J. Lipid Res. 48, 2162-2171.
36. Hatters, D. M., MacPhee, C. E., Lawrence, L. J., Sawyer, W. H., and Howlett, G. J. (2000) Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. Biochemistry 39, 8276-8283.
37. Binger, K. J., Pham, C. L., Wilson, L. M., Bailey, M. F., Lawrence, L. J., Schuck, P., and Howlett, G. J. (2008) Apolipoprotein C-II amyloid fibrils assemble via a reversible pathway that includes fibril breaking and rejoining. J. Mol. Biol. 376, 1116-1129.
38. Wang, C. S., Downs, D., Dashti, A., and Jackson, K. W. (1996) Isolation and characterization of recombinant human apolipoprotein C-II expressed in Escherichia coli. Biochim. Biophys. Acta 1302, 224-230.
39. Bohlen, P., Stein, S., Dairman, W., and Udenfriend, S. (1973) Fluorometric assay of proteins in the nanogram range. Arch. Biochem. Biophys. 155, 213-220.
40. Schuck, P. (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 78, 1606-1619.
41. MacRaild, C. A., Hatters, D. M., Lawrence, L. J., and Howlett, G. J. (2003) Sedimentation velocity analysis of flexible macromolecules: self-association and tangling of amyloid fibrils. Biophys. J. 84, 2562-2569.
42. Schuck, P., and Rossmanith, P. (2000) Determination of the sedimentation coefficient distribution by least-squares boundary modeling. Biopolymers 54, 328-341.
43. Wilson, L. M., Mok, Y. F., Binger, K. J., Griffin, M. D., Mertens, H. D., Lin, F., Wade, J. D., Gooley, P. R., and Howlett, G. J. (2007) A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. J. Mol. Biol. 366, 1639-1651.
44. Luhrs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Dobeli, H., Schubert, D., and Riek, R. (2005) 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl Acad. Sci. U.S.A. 102, 17342-17347.
45. Steinmetz, M. O., Gattin, Z., Verel, R., Ciani, B., Stromer, T., Green, J. M., Tittmann, P., Schulze-Briese, C., Gross, H., van Gunsteren, W. F., Meier, B. H., Serpell, L. C., Muller, S. A., and Kammerer, R. A. (2008) Atomic models of de novo designed ccbeta-Met amyloid-like fibrils. J. Mol. Biol. 376, 898-912.
46. O'Nuallain, B., Shivaprasad, S., Kheterpal, I., and Wetzel, R. (2005) Thermodynamics of abeta(1-40) amyloid fibril elongation. Biochemistry 44, 12709-12718.
47. Carulla, N., Caddy, G. L., Hall, D. R., Zurdo, J., Gairi, M., Feliz, M., Giralt, E., Robinson, C. V., and Dobson, C. M. (2005) Molecular recycling within amyloid fibrils. Nature 436, 554-558.
48. Abdul Latif, A. R., Kono, R., Tachibana, H., and Akasaka, K. (2007) Kinetic analysis of amyloid protofibril dissociation and volumetric properties of the transition state. Biophys. J. 92, 323-329.
49. Butterfield, D. A., and Bush, A. I. (2004) Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiol. Aging 25, 563-568.
50. Thylen, C., Wahlqvist, J., Haettner, E., Sandgren, O., Holmgren, G., and Lundgren, E. (1993) Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J. 12, 743-748.
51. Wadsworth, J. D., Asante, E. A., Desbruslais, M., Linehan, J. M., Joiner, S., Gowland, I., Welch, J., Stone, L., Lloyd, S. E., Hill, A. F., Brandner, S., and Collinge, J. (2004) Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306, 1793-1796.
52. Dai, X. L., Sun, Y. X., and Jiang, Z. F. (2007) Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution. FEBS Lett. 581, 1269-1274.
53. Squier, T. C. (2001) Oxidative stress and protein aggregation during biological aging. Exp. Gerontol. 36, 1539-1550.
54. Huang, X., Moir, R. D., Tanzi, R. E., Bush, A. L, and Rogers, J. T. (2004) Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann. N.Y. Acad. Sci. 1012, 153-163.
55. Stadtman, E. R., and Berlett, B. S. (1997) Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10, 485-494.
56. Berlett, B. S., and Stadtman, E. R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272, 20313-20316. BI8009339